Insider · CIK 0001789590
Jim L. Allen
Files at BCDA (BioCardia, Inc.). First filing -, latest -.
Jim L. Allen files SEC Form 4 as director at BCDA (BioCardia, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jim L. Allen has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | BCDA BioCardia, Inc. | AGrant or award Stock Option (right to buy)derivative | +8,000 | $0.00 | $0 | 23,313 | Jul 7, 2026 |
| Dec 8, 2025 | BCDA BioCardia, Inc. | AGrant or award Stock Option (right to buy)derivative | +12,000 | $0.00 | $0 | 15,313 | Dec 10, 2025 |
| Oct 11, 2024 | BCDA BioCardia, Inc. | AGrant or award Stock Option (right to buy)derivative | +829 | $0.00 | $0 | 3,313 | Oct 16, 2024 |
Questions about Jim L. Allen
Answered from the filings on this page, as of the latest one.
Is Jim L. Allen buying or selling?
Jim L. Allen has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jim L. Allen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jim L. Allen has 0.
Where does Jim L. Allen file Form 4?
Jim L. Allen has filed Form 4 at BCDA (BioCardia, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.